Peroxotitanates for biodelivery of metals.
Metal-based drugs are largely undeveloped in pharmacology. One limiting factor is the systemic toxicity of metal-based compounds. A solid-phase, sequestratable delivery agent for local delivery of metals could reduce systemic toxicity, facilitating new drug development in this nascent area. Amorphous peroxotitanates (APT) are ion-exchange materials with high affinity for several heavy metal ions and have been proposed to deliver or sequester metal ions in biological contexts. In the current study, we tested a hypothesis that APTs are able to deliver metals or metal compounds to cells. We exposed fibroblasts (L929) or monocytes (THP1) to metal-APT materials for 72 h in vitro and then measured cellular mitochondrial activity (SDH-MTT method) to assess the biological impact of the metal-APT materials versus metals or APT alone. APT alone did not significantly affect cellular mitochondrial activity, but all metal-APT materials suppressed the mitochondrial activity of fibroblasts (by 30-65% of controls). The concentration of metal-APT materials required to suppress cellular mitochondrial activity was below that required for metals alone, suggesting that simple extracellular release of the metals from the metal-APT materials was not the primary mechanism of mitochondrial suppression. In contrast to fibroblasts, no metal-APT material had a measurable effect on THP1 monocyte mitochondrial activity, despite potent suppression by metals alone. This latter result suggested that "biodelivery" by metal-APT materials may be cell type-specific. Therefore, it appears that APTs are plausible solid-phase delivery agents of metals or metal compounds to some types of cells for potential therapeutic effect.
Wataha
John C
JC
Department of Restorative Dentistry, University of Washington, Seattle, Washington 98026.
Hobbs
David T
DT
Savannah River National Laboratory, Aiken, South Carolina 29801.
Lockwood
Petra E
PE
Department of Oral Biology, Medical College of Georgia School of Dentistry, Augusta, Georgia 30912.
Davis
Ryan R
RR
Department of Oral Biology, Medical College of Georgia School of Dentistry, Augusta, Georgia 30912.
Elvington
Mark C
MC
Savannah River National Laboratory, Aiken, South Carolina 29801.
Lewis
Jill B
JB
Department of Oral Biology, Medical College of Georgia School of Dentistry, Augusta, Georgia 30912.
Messer
Regina L W
RLW
Department of Oral Biology, Medical College of Georgia School of Dentistry, Augusta, Georgia 30912.
D002460:Cell Line; D004396:Coloring Agents; D004305:Dose-Response Relationship, Drug; D004337:Drug Carriers / Q000737:chemistry*; D016503:Drug Delivery Systems; D005347:Fibroblasts / Q000187:drug effects; D006801:Humans; D008670:Metals / Q000008:administration & dosage* / Q000494:pharmacology / Q000633:toxicity; D019216:Metals, Heavy / Q000008:administration & dosage / Q000494:pharmacology / Q000633:toxicity; D008928:Mitochondria / Q000187:drug effects; D010087:Oxides / Q000737:chemistry*; D013385:Succinate Dehydrogenase / Q000378:metabolism; D013778:Tetrazolium Salts; D013844:Thiazoles; D014025:Titanium / Q000737:chemistry*
D004396:Coloring Agents; D004337:Drug Carriers; D008670:Metals; D019216:Metals, Heavy; D010087:Oxides; D013778:Tetrazolium Salts; D013844:Thiazoles; D014025:Titanium; D013385:Succinate Dehydrogenase; C022616:thiazolyl blue
Hobbs DT,Barnes MJ,Pulmano RL,Marshall KM,Edwards TB,Bronikowski MG,Fink SD. Strontium and actinide separations from high level nuclear waste solutions using monosodium titanate. I. Titanate simulant testing. Separ Sci Technol 2005; 40: 3093-3111.
Peters TB,Barnes MJ,Hobbs DT,Walker DD,Fondeur FF,Norato MA,Fink SD,Pulmano RL. Strontium and actinide separations for high level nuclear waste solutions using monosodium titanate. II. Actual waste testing. Separ Sci Technol 2006; 41: 2409-2427.
Nyman M,Hobbs DT. A family of peroxo-titanate materials tailored for optimal strontium and actinide sorption. Chem Mater 2006; 18: 6425-6435.
Hobbs DT,Nyman MD,Piorier MR,Barnes MJ,Stallings ME. Development of improved sodium titanate for the pretreatment of nuclear waste at the Savannah River Site. Proceedings of the Symposium on Waste Management, Tucson, AZ, February 26-March 02, 2006.
Hobbs DT,Messer RLW,Lewis JB,Click DR,Lockwood PE,Wataha JC Adsorption of biometals to monosodium titanate in biological environments. J Biomed Mater Res Part B: Appl Biomater 2006; 78: 296-301.
Davis RR,Lockwood PE,Hobbs DT,Messer RLW,Price RJ,Lewis JB,Wataha JC. In vitro biological effects of sodium titanate materials. J Biomed Mater Res Part B: Applied Biomater 2007; 83: 505-511.
Kean WF,Hart L,Buchanan WW. Auranofin. Brit J Rheumatol 1997; 36: 560-572.
Davis RR,Hobbs DT,Khashaba R,Sehkar P,Seta FN,Messer RLW,Lewis JB,Wataha JC. Titanate particles as agent to deliver gold compounds to fibroblasts and monocytes. J Biomed Mater Res Part A, January 2009.
Holbrook DJ,Washington ME,Leake HB,Brubaker PE. Studies on the evaluation of the toxicity of various salts of lead, manganese, platinum, and palladium. Environ Health Perspect 1975; 10: 95-101.
Holbrook DJ,Washington ME,Leake HB,Brubaker PE. Effects of platinum and palladium salts on parameters of drug metabolism in rat liver. J Toxicol Environ Health 1976; 1: 1067-1079.
Das M,Livingstone SE. Metal chelates as anti-cancer agents. II. Cytotoxic action of palladium and platinum complexes of 6-mercaptopurine and thioguanine. Br J Cancer 1978; 38: 325-328.
Mital R,Shah GM,Srivastava TS,Bhattacharya RK. The effect of some new platinum (II) and palladium (II) coordination complexes on rat hepatic nuclear transcription in vitro. Life Sci 1992; 50: 781-790.
Fisher RF,Holbrook DJ,Leake HB,Brubaker PE. Effect of platinum and palladium salts on thymidine incorporation into DNA of rat tissues. Environ Health Perspect 1975; 12: 57-62.
Sheard C. Contact dermatitis from platinum and related metals. Arch Dermatol 1955; 71: 357-360.
Clarkson TW,Magos M,Myers GJ. Current concepts-The toxicology of mercury-Current exposures and clinical manifestations. N Eng J Med 2003; 349: 1731-1737.
Clarkson TW,Magos L. The toxicology of mercury and its chemical compounds. Crit Rev Toxicol 2006; 36: 609-662.
Magos L,Clarkson TW. Overview of the clinical toxicity of mercury. Ann Clin Biochem 2006; 43: 257-268.
Clarkson TW,Magos L,Myers GJ. Human exposure to mercury: The three modern dilemmas. J Trace Elem Exp Med 2003; 16: 321-343.
Hambley TW. The influence of structure on the activity and toxicity of Pt anti-cancer drugs. Coordination Chem Rev 1997; 166: 181-223.
Leyendecker JR,Barnes CE,Zagoria RJ. MR urography: Techniques and clinical applications. Radiographics 2008; 28: 23-47.
Strijkers GJ,Mulder JM,van Tilborg AF,Nicolay K. MRI contrast agents: Current status and future perspectives. Anti-Cancer Agents Med Chem 2007; 7: 291-305.
Bottril M,Kwok L,Long NJ. Lanthanides in magnetic resonance imaging. Chem Soc Rev 2006; 35: 557-571.
Caravan P. Strategies of increasing the sensitivity of gadolinium based MRI contrast agents. Chem Soc Rev 2006; 35: 512-523.
Halámiková A,Heringová P,Kasparková J,Intini FP,Natile G,Nemirovski A,Gibson D,Brabec V. Cytotoxicity, mutagenicity, cellular uptake, DNA and glutathione interactions of lipophilic trans-platinum complexes tethered to 1-adamatylamie. J Inorg Biochem 2008; 102: 1077-1089.
Kostova I,Mornekov G,Stancheva P. New samarium (III), gadolinium (III), and dysprosium (III) complexes of coumarin-3-carboxylic acid as antiproliferative agents. Met Based Drugs 2007; 2007: 15925.
Wataha JC,Hanks CT,Craig RG. The in vitro effects of metal cations on eukaryotic cell metabolism. J Biomed Mater Res 1991; 25: 1133-1149.
Wataha JC,Hanks CT,Sun ZL. In vitro reaction of macrophages to metal ions from dental biomaterials. Dent Mater 1995; 11: 239-245.
Wataha JC,Hanks CT,Sun ZL. Effect of cell line on in vitro metal ion cytotoxicity. Dent Mater 1994; 10: 156-161.
Cotton FA,Wilkinson G. Advanced Inorganic Chemistry, 3rd ed. New York. Interscience; 1972.